However, only 12% of LSCC samples presented ALCAM copy number gain/amplification associated with its overexpression, suggesting that further mechanisms, such as DNA methylation, already shown to be associated with ALCAM overexpression in breast tumors [36], may also be associated with this deregulation in LSCC. The gene discussed is ALCAM; the disease is breast neoplasm.